{"id":17542,"date":"2014-01-23T02:30:00","date_gmt":"2014-01-23T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/calabria-pharma-bluff-joppolo-truffa-sui-farmaci-arrestati-giuseppe-dato-giuseppina-scinica-francesco-d%c2%92agostino-e-carmen-ferraro\/"},"modified":"2014-01-23T02:30:00","modified_gmt":"2014-01-23T01:30:00","slug":"calabria-pharma-bluff-joppolo-truffa-sui-farmaci-arrestati-giuseppe-dato-giuseppina-scinica-francesco-d%c2%92agostino-e-carmen-ferraro","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/calabria-pharma-bluff-joppolo-truffa-sui-farmaci-arrestati-giuseppe-dato-giuseppina-scinica-francesco-d%c2%92agostino-e-carmen-ferraro\/","title":{"rendered":"Calabria. Pharma bluffing. Joppolo, drug scam. Arrested Giuseppe Dato, Giuseppina Scinica, Francesco D'Agostino and Carmen Ferraro"},"content":{"rendered":"

egr. Dr. Cherubini,<\/p>\n

<\/font><\/span><\/p>\n

I have been a Pharmaceutical Representative for 23 years and in the last five I have been dealing with expired patent drugs, often included as a reference in the various international guidelines.<\/p>\n

<\/font><\/span><\/p>\n

Once again, I read with considerable disappointment the manipulation of public documents by AssoGenerici in the dissemination of press releases aimed at doctors and citizens to promote the use of generic drugs; promotion is legitimate, scientific disinformation is not, and I say this as a citizen and as an ISF. On the merits, in the press release dated May 18 on the "Campania model" we read: "The regional law of Campania on the prescription of generics <\/b>and biosimilars is an important fact because it guarantees not only the economic compatibility of territorial and hospital pharmaceutical assistance, but it follows a different path from that of rationing services, with the possibility of obtaining savings even higher than those deriving from the application of produced by the Medicines Agency"<\/i>.<\/p>\n

<\/font><\/span><\/p>\n

The text of the Decree is very different from what - quoting Vice President Colantuoni - one would like to have believed; already in the title is denied what AssoGenerici declaimed in the press release in question:<\/p>\n

<\/font><\/span><\/p>\n

DECREE no. 27 of 03.15.2013<\/p>\n

<\/font><\/span><\/i><\/b><\/p>\n

ref. letter g)<\/p>\n

<\/font><\/span><\/i><\/b><\/p>\n

Subject: incentive measures for the prescription of off-patent drugs<\/span><\/u> and of drugs<\/p>\n

<\/font><\/span><\/i><\/b><\/p>\n

biosimilars.<\/p>\n

<\/font><\/span><\/i><\/b><\/p>\n

As AssoGenerici's communication manager, Dr. Cherubini, I invite you to re-read the Decree itself more carefully <\/span>(http:\/\/www.quotidianosanita.it\/allegati\/allegato7890486.pdf<\/font><\/a>), in the belief that on your part there was no malevolent and distorting interpretation in translating "expired patent drugs" <\/i>with "generics"<\/i>, but an oversight related to the company name of his employer. However, this AssoGenerici press release is the umpteenth (and, alas, I don't think even the last) act that manipulates the reality of drugs no longer covered by short protection<\/p>","protected":false},"excerpt":{"rendered":"

Egr. Dr. Cherubini, sono un Informatore Scientifico del Farmaco da 23 anni e negli ultimi cinque mi sto occupando di farmaci a brevetto scaduto, spesso inseriti a riferimento nelle varie linee guida internazionali. Leggo, ancora una volta, con notevole disappunto la manipolazione di atti pubblici da parte di AssoGenerici nella divulgazione di comunicati rivolti alla …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17542"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}